Protein tyrosine phosphatase receptor-type O (PTPRO) exhibits characteristics of a candidate tumor suppressor in human lung cancer - Wikidata - thesis-toulmin - TriplyDB

Protein tyrosine phosphatase receptor-type O (PTPRO) exhibits characteristics of a candidate tumor suppressor in human lung cancer

Protein tyrosine phosphatase receptor-type O (PTPRO) exhibits characteristics of a candidate tumor suppressor in human lung cancer

http://www.wikidata.org/entity/Q24564615

about

GLEPP1/protein-tyrosine phosphatase phi inhibitors block chemotaxis in vitro and in vivo and improve murine ulcerative colitis Methylation and silencing of protein tyrosine phosphatase receptor type O in chronic lymphocytic leukemia MicroRNA-122 inhibits tumorigenic properties of hepatocellular carcinoma cells and sensitizes these cells to sorafenib Down-regulation of micro-RNA-1 (miR-1) in lung cancer. Suppression of tumorigenic property of lung cancer cells and their sensitization to doxorubicin-induced apoptosis by miR-1 Methylation mediated silencing of MicroRNA-1 gene and its role in hepatocellular carcinogenesis Allelic imbalances and microdeletions affecting the PTPRD gene in cutaneous squamous cell carcinomas detected using single nucleotide polymorphism microarray analysis Small molecule tools for functional interrogation of protein tyrosine phosphatases Protein tyrosine phosphatase receptor-type O (PTPRO) is co-regulated by E2F1 and miR-17-92 5-Aza-deoxycytidine induces selective degradation of DNA methyltransferase 1 by a proteasomal pathway that requires the KEN box, bromo-adjacent homology domain, and nuclear localization signal A folate- and methyl-deficient diet alters the expression of DNA methyltransferases and methyl CpG binding proteins involved in epigenetic gene silencing in livers of F344 rats Identification of ptpro as a novel target gene of Wnt signaling and its potential role as a receptor for Wnt Role of protein tyrosine phosphatases in cancer A high-temporal resolution technology for dynamic proteomic analysis based on 35S labeling.Aberrant PTPRO methylation in tumor tissues as a potential biomarker that predicts clinical outcomes in breast cancer patients.Epigenetically silenced PTPRO functions as a prognostic marker and tumor suppressor in human lung squamous cell carcinoma.A new class of quinoline-based DNA hypomethylating agents reactivates tumor suppressor genes by blocking DNA methyltransferase 1 activity and inducing its degradation.Lyn kinase and ZAP70 are substrates of PTPROt in B-cells: Lyn inactivation by PTPROt sensitizes leukemia cells to VEGF-R inhibitor pazopanib Protein tyrosine phosphatase kappa (PTPRK) is a negative regulator of adhesion and invasion of breast cancer cells, and associates with poor prognosis of breast cancer.Methylation of the PTPRO gene in human hepatocellular carcinoma and identification of VCP as its substrate.Epigenetic regulation of protein tyrosine phosphatases: potential molecular targets for cancer therapy.Methylator phenotype of malignant germ cell tumours in children identifies strong candidates for chemotherapy resistance.Integrated genomic analysis of relapsed childhood acute lymphoblastic leukemia reveals therapeutic strategies.AP-1 elements and TCL1 protein regulate expression of the gene encoding protein tyrosine phosphatase PTPROt in leukemia Aberrant methylation of the PTPRO gene in peripheral blood as a potential biomarker in esophageal squamous cell carcinoma patients.PTPROt-mediated regulation of p53/Foxm1 suppresses leukemic phenotype in a CLL mouse model PTPRO-mediated autophagy prevents hepatosteatosis and tumorigenesis Prognostic implication of PTPRH hypomethylation in non-small cell lung cancer.Epigenetic reprogramming reverses the relapse-specific gene expression signature and restores chemosensitivity in childhood B-lymphoblastic leukemia.Expression profiling during mammary epithelial cell three-dimensional morphogenesis identifies PTPRO as a novel regulator of morphogenesis and ErbB2-mediated transformation Protein-tyrosine phosphatases and cancer.TCPTP regulates SFK and STAT3 signaling and is lost in triple-negative breast cancers.Estrogen-mediated suppression of the gene encoding protein tyrosine phosphatase PTPRO in human breast cancer: mechanism and role in tamoxifen sensitivity PTPRO promoter methylation is predictive of poorer outcome for HER2-positive breast cancer: indication for personalized therapy BCL6 modulates tonic BCR signaling in diffuse large B-cell lymphomas by repressing the SYK phosphatase, PTPROt.PTPRO represses ERBB2-driven breast oncogenesis by dephosphorylation and endosomal internalization of ERBB2 MicroRNA dysregulation during chemical carcinogenesis.Receptor-type protein tyrosine phosphatases in cancer.Interaction of PTPRO and TLR4 signaling in hepatocellular carcinoma.Molecular Pathways: Targeting Protein Tyrosine Phosphatases in Cancer.PTPROt inactivates the oncogenic fusion protein BCR/ABL and suppresses transformation of K562 cells

P2860

Q24313112-20E84779-169C-43FB-8EEE-55D5801DB595 Q24619893-B29BFB40-435B-4387-A3D5-54EEEEBD9CC9 Q24655048-9E7AB60E-25BA-4003-979D-AF083FFBE382 Q24655144-32E98C4D-FD4D-4FCF-88A5-C437B2D7599F Q24656948-2929CF38-DC32-442F-A0C2-265FEE02F74D Q24657188-1B5CB4F6-3D1D-4052-9674-3FD141CD0CE3 Q26852276-685D2144-A683-42DC-9CAE-7D0B2BFACC68 Q28288074-C16DB351-402D-4018-A712-13189B0539C4 Q28384242-4532E64B-0B02-4A60-BCC3-7D575DDDA00C Q28566367-C9C53D34-A07E-4DE5-AE4F-CCEE143EAC2B Q28593013-4F544DC3-94C4-4A18-86C0-85AB55B22D5C Q28741003-31F339A5-2E48-4EB1-B576-250F7DFC2C0D Q33361615-7E8740F9-0546-4AC8-B5A6-AAB3120F8501 Q33775528-A4584E54-3D75-4764-AAA6-C47811887A38 Q33828327-FC919EAE-D58D-4A88-A6DB-905A0EDF9520 Q33901844-B450A6FE-AEB2-4E19-A486-31BB65A6D5C8 Q33952692-0406902F-CF0F-40A1-87E7-AA1D87D73254 Q34336836-DCF68921-2997-42BE-8AD7-8ABAC2148320 Q34349289-2B5D68A8-3CA9-4E2D-BA94-4EFAB1E0F3F8 Q34528296-EFF781ED-B429-4D59-9EFC-E22231CCF454 Q35208036-1A69B908-1B46-42BE-AFDF-41CF0C3D10BC Q35553581-99F21707-4931-42B3-B0A7-39FAAFC0E8E2 Q35604063-A415E043-C512-4CC1-99EA-7B6A68BF4F4A Q35643156-28D6DD64-2234-4EC7-9ADE-8DF2FF91D2F5 Q35685290-46718F67-2B99-4D81-AB0E-2E29546D3220 Q35832384-B16900FB-B89A-481F-89D0-8E709D458782 Q35934571-FE2D0F64-AF56-4773-A46D-4BAE7A878D4A Q36015007-4DB87693-74CC-497A-8242-5A2E0EDEED02 Q36277279-93860A0C-9B04-4055-9CEB-D2CB554DF6B6 Q36430193-5943B386-E4C6-4639-B0C0-3F7A1776A4A5 Q36560020-62869B4D-2C5C-4132-82B2-DD57F663DB68 Q37106891-52364CBD-C3F8-4363-AF61-9F5ABBA8A647 Q37367387-02AD7F73-FDB3-4E9A-88A8-513C411B40F4 Q37484499-863B88D7-5B1E-4F11-96BA-5C0954EA50DF Q37609203-41362800-1A69-4307-9CC3-3573263D2EE7 Q37962000-7642E6B6-7260-4B25-B8B0-C1ACE7712FBE Q38260826-36C80119-31B3-481D-8F93-2E639CBBFB61 Q38974538-D1AD8CD2-2589-43FC-A917-04C973CE151E Q39088131-3F992E52-EEF1-454D-9444-78422A7074EE Q39919462-1B1B92EE-BCDC-4136-8354-8E630A873744

P2860

Protein tyrosine phosphatase receptor-type O (PTPRO) exhibits characteristics of a candidate tumor suppressor in human lung cancer

http://www.wikidata.org/entity/Q24564615

description

2004 nî lūn-bûn

@nan

2004 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2004 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

name

Protein tyrosine phosphatase r ...... uppressor in human lung cancer

@ast

Protein tyrosine phosphatase r ...... uppressor in human lung cancer

@en

Protein tyrosine phosphatase r ...... uppressor in human lung cancer

@nl

type

label

Protein tyrosine phosphatase r ...... uppressor in human lung cancer

@ast

Protein tyrosine phosphatase r ...... uppressor in human lung cancer

@en

Protein tyrosine phosphatase r ...... uppressor in human lung cancer

@nl

prefLabel

Protein tyrosine phosphatase r ...... uppressor in human lung cancer

@ast

Protein tyrosine phosphatase r ...... uppressor in human lung cancer

@en

Protein tyrosine phosphatase r ...... uppressor in human lung cancer

@nl

P1433

Q24564615-866B9847-2D92-4884-BA91-32C23FF8935A

P1476

Q24564615-9B9544B1-5C69-4F3D-9457-2982506129A9

P2093

Q24564615-362249B4-2B0B-4CF1-BABD-4211B9443438

Q24564615-55FFE3F5-C896-439B-A87F-DC19A70B4018

Q24564615-6FE15AE6-C43C-41F9-A98C-A0E5F305B7C3

Q24564615-8E43DA87-86EC-438C-882F-11455F0F82B0

Q24564615-C6EDF7C1-310E-43F5-8F5A-9D3ECB2449A0

Q24564615-DC3E22B4-8E26-40F8-873B-0EA81853783F

Q24564615-E4E53B43-A991-409E-A5AB-804B547A4228

Q24564615-EF3DE74C-09A5-4E9B-BB04-32B6FDD66A7E

Q24564615-F49BFEC9-6163-4C49-8208-934EB185A189

P2860

Q24564615-09CF213E-E398-446E-8CD4-CBB76BC7567E

Q24564615-1377994D-C6ED-4E73-A5F1-541070B064A2

Q24564615-1E049E85-38F5-43B3-9D8C-B56BDF169D16

Q24564615-1EDB4A88-F98F-4805-89FA-9116A7661AE9

Q24564615-27AB7A5F-FC24-417A-B515-8E0CFF2D5DDA

Q24564615-2F14BF27-EDE7-4923-88F6-6F72F70A6C5F

Q24564615-30AD85CD-D338-410F-962B-E47DFB80EB9B

Q24564615-37FA0E3B-74E5-40AD-BDE5-63650F033E69

Q24564615-3DB7B59D-1FBA-4D11-A1B9-635CEC77E5FF

Q24564615-3EF4FF4D-4564-452A-9A0C-E40695FC503D

P304

Q24564615-3A7A979C-B3CE-47F8-B448-F0182B8FF1F7

P31

Q24564615-90B552CC-971A-43CC-B341-0EF435666CE0

P3181

Q24564615-C7D4BA3E-CACE-434F-AA74-0A93393FDFCF

P356

Q24564615-19F359B2-C8A0-4AD8-BD3C-FACA8CD1F357

P407

Q24564615-83CBF094-689B-4A58-91F7-A48A8FF573A5

P433

Q24564615-C817FF0E-97D4-4B92-8B5C-A0F1A0579C53

P478

Q24564615-0158A6BC-CEFA-438D-99A7-4B0D1786EDBA

P577

Q24564615-7A6840EC-4FCA-469B-B3B8-04498336E5EF

P5875

Q24564615-B777B3BC-BAAF-4F50-BD2A-502F88CA3507

P698

Q24564615-0E4C7A9E-A870-4361-8D4C-ABF23AEFF200

P932

Q24564615-F014672D-8B8C-4268-980C-097AF718FC6B

P3181

P356

PNAS.0405451101

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Protein tyrosine phosphatase r ...... uppressor in human lung cancer

@en

P2093

Carl Morrison

http://www.w3.org/2001/XMLSchema#string

Hiroyuki Seimiya

http://www.w3.org/2001/XMLSchema#string

Huban Kutay

http://www.w3.org/2001/XMLSchema#string

Kalpana Ghoshal

http://www.w3.org/2001/XMLSchema#string

Samson T Jacob

http://www.w3.org/2001/XMLSchema#string

Saul Suster

http://www.w3.org/2001/XMLSchema#string

Shoumei Bai

http://www.w3.org/2001/XMLSchema#string

Takashi Tsuruo

http://www.w3.org/2001/XMLSchema#string

Tasneem Motiwala

http://www.w3.org/2001/XMLSchema#string

P2860

PTPROt: an alternatively spliced and developmentally regulated B-lymphoid phosphatase that promotes G0/G1 arrest

Identification of a novel thioredoxin-related transmembrane protein

Hepatocyte growth factor receptor tyrosine kinase met is a substrate of the receptor protein-tyrosine phosphatase DEP-1

Molecular cloning of cDNAs encoding human GLEPP1, a membrane protein tyrosine phosphatase: characterization of the GLEPP1 protein distribution in human kidney and assignment of the GLEPP1 gene to human chromosome 12p12-p13

Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction

Reciprocal regulation of lymphocyte activation by tyrosine kinases and phosphatases

Identification of a receptor-type protein tyrosine phosphatase expressed in postmitotic maturing neurons: its structure and expression in the central nervous system

Gene silencing in cancer in association with promoter hypermethylation

Suppression of the protein tyrosine phosphatase receptor type O gene (PTPRO) by methylation in hepatocellular carcinomas

Combinatorial control of the specificity of protein tyrosine phosphatases.

P304

13844-9

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

4744925

http://www.w3.org/2001/XMLSchema#string

P356

10.1073/PNAS.0405451101

http://www.w3.org/2001/XMLSchema#string

P407

P433

38

http://www.w3.org/2001/XMLSchema#string

P478

101

http://www.w3.org/2001/XMLSchema#string

P577

2004-09-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8358386

http://www.w3.org/2001/XMLSchema#string

P698

15356345

http://www.w3.org/2001/XMLSchema#string

P932

518843

http://www.w3.org/2001/XMLSchema#string